FR2354101A1 - Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques - Google Patents

Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques

Info

Publication number
FR2354101A1
FR2354101A1 FR7717842A FR7717842A FR2354101A1 FR 2354101 A1 FR2354101 A1 FR 2354101A1 FR 7717842 A FR7717842 A FR 7717842A FR 7717842 A FR7717842 A FR 7717842A FR 2354101 A1 FR2354101 A1 FR 2354101A1
Authority
FR
France
Prior art keywords
cellulitic
infiltrates
preparation
compound
treating fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7717842A
Other languages
English (en)
French (fr)
Other versions
FR2354101B1 (ru
Inventor
Max Schibli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berema SA
Original Assignee
Berema SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berema SA filed Critical Berema SA
Publication of FR2354101A1 publication Critical patent/FR2354101A1/fr
Application granted granted Critical
Publication of FR2354101B1 publication Critical patent/FR2354101B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7717842A 1976-06-10 1977-06-10 Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques Granted FR2354101A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH734376A CH622703A5 (en) 1976-06-10 1976-06-10 Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite

Publications (2)

Publication Number Publication Date
FR2354101A1 true FR2354101A1 (fr) 1978-01-06
FR2354101B1 FR2354101B1 (ru) 1980-02-15

Family

ID=4323632

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717842A Granted FR2354101A1 (fr) 1976-06-10 1977-06-10 Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques

Country Status (2)

Country Link
CH (1) CH622703A5 (ru)
FR (1) FR2354101A1 (ru)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2433943A1 (fr) * 1977-06-03 1980-03-21 Berema Sa Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
JPS59155313A (ja) * 1982-12-10 1984-09-04 フランク・エル・グリ−ンウエイ・ザ・サ−ド 体重の選択的減量のための組成物
WO1991000726A1 (fr) * 1989-07-13 1991-01-24 Parfums Christian Dior UTILISATION D'AMPc OU SES DERIVES POUR LA PREPARATION DE COMPOSITIONS COSMETIQUE OU PHARMACEUTIQUE
WO1991011181A1 (en) * 1990-02-05 1991-08-08 British Technology Group (Usa) Incorporated Thyroid hormone cardiac treatment
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
WO1996040048A2 (en) * 1995-06-07 1996-12-19 Karo Bio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
WO2002089917A2 (en) * 2001-05-09 2002-11-14 Karo Bio Ab Dermatological formulations

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701258D0 (sv) * 1987-03-26 1987-03-26 Pharmacia Ab A composition for the topical treatment of glaucoma or ocular hypertension
SE461013B (sv) * 1988-02-11 1989-12-18 Christian Wesslau Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2139748A1 (ru) * 1971-06-03 1973-01-12 Prugnaud Robert
FR2142675A1 (en) * 1971-06-23 1973-02-02 Egema Sa Triiodothyroalkanoic acid derivs - for treating lipid overload and celluitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2139748A1 (ru) * 1971-06-03 1973-01-12 Prugnaud Robert
FR2142675A1 (en) * 1971-06-23 1973-02-02 Egema Sa Triiodothyroalkanoic acid derivs - for treating lipid overload and celluitis

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515962A1 (fr) * 1977-06-03 1983-05-13 Berema Sa Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
FR2433943A1 (fr) * 1977-06-03 1980-03-21 Berema Sa Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
JPH0653681B2 (ja) * 1982-12-10 1994-07-20 フランク・エル・グリ−ンウエイ・ザ・サ−ド 体重の選択的減量のための組成物
JPS59155313A (ja) * 1982-12-10 1984-09-04 フランク・エル・グリ−ンウエイ・ザ・サ−ド 体重の選択的減量のための組成物
EP0120165A2 (en) * 1982-12-10 1984-10-03 Greenway III, Frank L. A preparation and a process for achieving regional weight control
EP0120165A3 (en) * 1982-12-10 1985-06-19 Frank L. Greenway Iii A preparation and a process for achieving regional weight control
WO1991000726A1 (fr) * 1989-07-13 1991-01-24 Parfums Christian Dior UTILISATION D'AMPc OU SES DERIVES POUR LA PREPARATION DE COMPOSITIONS COSMETIQUE OU PHARMACEUTIQUE
WO1991011181A1 (en) * 1990-02-05 1991-08-08 British Technology Group (Usa) Incorporated Thyroid hormone cardiac treatment
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
WO1996040048A2 (en) * 1995-06-07 1996-12-19 Karo Bio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
WO1996040048A3 (en) * 1995-06-07 1997-11-13 Karobio Ab Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
EP1398024A3 (en) * 1995-06-07 2004-12-15 Karo Bio Ab uses for thyroid hormones compounds
WO2002089917A2 (en) * 2001-05-09 2002-11-14 Karo Bio Ab Dermatological formulations
WO2002089917A3 (en) * 2001-05-09 2003-08-21 Karobio Ab Dermatological formulations

Also Published As

Publication number Publication date
FR2354101B1 (ru) 1980-02-15
CH622703A5 (en) 1981-04-30

Similar Documents

Publication Publication Date Title
KR920702217A (ko) 말라리아 치료 조성물
FR2354101A1 (fr) Preparation pour traiter les surcharges graisseuses et les infiltrats cellulitiques
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
DK0518989T3 (da) Parasiticide præparater og fremgangsmåder til fremstilling og anvendelse deraf
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
ATE6988T1 (de) Antimykotische mittel mit hoher wirkstofffreisetzung in form von stiften.
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
NL7611448A (nl) Werkwijze voor het bereiden van trichloormethyl- -trifluormethylbenzenen, werkwijze voor het be- reiden van preparaten met bactericide en fungi- cide werking onder toepassing van deze verbin- dingen, alsmede de gevormde preparaten.
AU530678B2 (en) Phosphono-hydroxy-acetic acid
SE8403659D0 (sv) Synergistic pharmaceutical composition
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
NL7611449A (nl) Werkwijze voor het bereiden van trichloormethyl- -trifluormethylbenzenen, werkwijze voor het be- reiden van preparaten met insecticide en fungi- cide werking onder toepassing van deze verbin- dingen, alsmede de gevormde preparaten.
ES385672A2 (es) Un procedimiento para preparar una composicion pesticida.
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
SE7607630L (sv) Forening for behandling av bovin mastit
DK0436015T3 (da) Farmaceutisk præparat til rektal indgift
IL57058A (en) Dichlorobenzodioxole derivatives,their preparation and their use as synergistic agents in insecticidal and acaricidal compositions
JPS55120510A (en) Composition for oral cavity
SE7411917L (ru)
ZA795459B (en) Use of n,n-dimethyl-n'-p-tolyl-n'-dichloro-fluoromethylthio-sulphamide for combating fungi which damage wood
GB889049A (en) Veterinary compositions comprising prednisolone 21-trimethylacetate
GB830868A (en) Compositions for treating animals to eliminate hookworms and ascarids
ES430308A1 (es) Un metodo para la preparacion de una formulacion inyectableen una sola fase.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse